PCD Drug Pipeline

Track the development of potential treatments for Primary Ciliary Dyskinesia

Hide Filters

Refine Pipeline

Tailor your results by using the filters below.

Development Phase

Therapeutic Approach

Click on any drug in the interactive pipeline below to learn more about PCD drugs in development or already in use by patients.

Restore Ciliary Function

Treatments that aim to improve ciliary function in PCD patients
Pre-clinical
Phase One
Phase Two
Phase Three
To Patients
ETH42
RCT1100

Anti-Inflammatory

Treatments that reduce inflammation in the airways of PCD patients
Pre-clinical
Phase One
Phase Two
Phase Three
To Patients
Brensocatib